ACCESSION: MSBNK-SMB_Measured-HSA033P0193000
RECORD_TITLE: Annotated; Allantoin; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 40
COMMENT: RAW_SPEC {'D147neg_2790': {'bp': 4227.0, 'sum': 13029.0}, 'D147neg_2712': {'bp': 3999.0, 'sum': 9143.0}, 'D73neg_2640': {'bp': 3525.0, 'sum': 11318.0}, 'D64neg_2718': {'bp': 3258.0, 'sum': 8504.0}, 'D168neg_2674': {'bp': 3193.0, 'sum': 10769.0}, 'D87neg_2653': {'bp': 3106.0, 'sum': 9596.0}, 'D99neg_2631': {'bp': 2995.0, 'sum': 9336.0}, 'D126neg_2686': {'bp': 2978.0, 'sum': 8264.0}, 'D73neg_2625': {'bp': 2662.0, 'sum': 6933.0}, 'D102neg_2576': {'bp': 2537.0, 'sum': 5912.0}, 'D122neg_2723': {'bp': 2500.0, 'sum': 7777.0}, 'D83neg_2752': {'bp': 2445.0, 'sum': 6206.0}, 'C8neg_2593': {'bp': 2419.0, 'sum': 8001.0}, 'D108neg_2679': {'bp': 2292.0, 'sum': 6487.0}, 'D64neg_2666': {'bp': 2172.0, 'sum': 5824.0}, 'D102neg_2629': {'bp': 2069.0, 'sum': 6307.0}, 'D171neg_2602': {'bp': 2044.0, 'sum': 6304.0}, 'C18neg_2636': {'bp': 1871.0, 'sum': 5790.0}, 'D108neg_2601': {'bp': 1796.0, 'sum': 5625.0}, 'D168neg_2649': {'bp': 1712.0, 'sum': 5750.0}, 'D66neg_2652': {'bp': 1675.0, 'sum': 4204.0}, 'C6neg_2661': {'bp': 1667.0, 'sum': 4880.0}, 'C5neg_2625': {'bp': 1641.0, 'sum': 5239.0}, 'D126neg_2662': {'bp': 1626.0, 'sum': 4780.0}, 'C9neg_2603': {'bp': 1567.0, 'sum': 5564.0}, 'C14neg_2520': {'bp': 1532.0, 'sum': 3877.0}, 'D94neg_2617': {'bp': 1433.0, 'sum': 4029.0}, 'C11neg_2588': {'bp': 1408.0, 'sum': 3870.0}, 'D83neg_2794': {'bp': 1390.0, 'sum': 4322.0}, 'D65neg_2716': {'bp': 1318.0, 'sum': 4181.0}, 'D170neg_2622': {'bp': 1274.0, 'sum': 3447.0}, 'C7neg_2631': {'bp': 1257.0, 'sum': 3640.0}, 'C2neg_2691': {'bp': 1146.0, 'sum': 3145.0}, 'D143neg_2585': {'bp': 1068.0, 'sum': 3737.0}, 'D65neg_2665': {'bp': 1063.0, 'sum': 3252.0}, 'C13neg_2708': {'bp': 1033.0, 'sum': 2361.0}, 'C5neg_2676': {'bp': 976.0, 'sum': 2959.0}, 'D121neg_2583': {'bp': 918.0, 'sum': 2931.0}, 'D207neg_2682': {'bp': 856.0, 'sum': 2477.0}, 'C3neg_2644': {'bp': 628.0, 'sum': 1943.0}}
COMMENT: RETENTION_TIME_STDEV 0.026
COMMENT: PRECURSOR_M/Z_RAW 193.012763
COMMENT: PRECURSOR_M/Z_STDEV 0.000779
COMMENT: PRECURSOR_IN_MS1 mz 193.012988; int 26.626; delta(ppm) -0.582133
COMMENT: PROPOSED_CHARGE_STATE -1; mz 194.015172; int 1.680; cor 0.633
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 228.990012; int 1.016; cor 0.651
COMMENT: PROPOSED_ION_FORM M+Cl; M-H; mz 157.036614; int 234.796; cor 0.740
COMMENT: PROPOSED_MAX_NUM_S 8
COMMENT: PROPOSED_MF SevenGoldenRules 13.731; C10H2N4O; [M-H]1; delta(ppm) -13.730529
COMMENT: PROPOSED_MF SevenGoldenRules 11.313; C10H10S2; [M-H]1; delta(ppm) -11.313255
COMMENT: PROPOSED_MF SevenGoldenRules 6.834; C9H6O5; [M-H]1; delta(ppm) -6.834340
COMMENT: PROPOSED_MF SevenGoldenRules 6.061; C13H6S; [M-H]1; delta(ppm) 6.061225
COMMENT: PROPOSED_MF SevenGoldenRules 9.417; C5H10N2O2S2; [M-H]1; delta(ppm) 9.416545
COMMENT: PROPOSED_MF SevenGoldenRules 18.282; C6H11O3SP; [M-H]1; delta(ppm) 18.281602
COMMENT: PROPOSED_MF SevenGoldenRules 2.980; C4H6N4O3; [M+Cl]1; delta(ppm) -2.980192
COMMENT: PROPOSED_MF SevenGoldenRules 13.281; C7H12P2; [M+Cl]1; delta(ppm) 13.281152
COMMENT: PROPOSED_MF MS-FINDER 4.112; C4H6N4O3; [M+Cl]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF MS-FINDER 2.895; C5H10N2O2S2; [M-H]-; delta(ppm) 9.470202
COMMENT: PROPOSED_MF MS-FINDER 2.684; C9H6O5; [M-H]-; delta(ppm) -6.869283
COMMENT: PROPOSED_MF MS-FINDER 2.610; C3H7N4O4P; [M-H]-; delta(ppm) -1.514451
COMMENT: PROPOSED_MF MS-FINDER 2.156; C4H6N2O7; [M-H]-; delta(ppm) 13.972688
COMMENT: PROPOSED_MF MS-FINDER 1.944; C5H2N6O3; [M-H]-; delta(ppm) 7.043400
COMMENT: PROPOSED_MF MS-FINDER 1.943; C4H14O2S2; [M+Cl]-; delta(ppm) -110592.502634
COMMENT: PROPOSED_MF MS-FINDER 1.623; C6H11O3PS; [M-H]-; delta(ppm) 18.378460
COMMENT: PROPOSED_MF MS-FINDER 1.609; C13H6S; [M-H]-; delta(ppm) 6.094140
COMMENT: PROPOSED_MF MS-FINDER 1.594; C10H10S2; [M-H]-; delta(ppm) -11.371581
COMMENT: PROPOSED_MF MS-FINDER 1.511; C10H2N4O; [M-H]-; delta(ppm) -13.798282
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.767; C4H6N4O3; [M+Cl]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H6N4O3; [M+Cl]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.201; C4H7ClN4O3; [M-H]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.921; C3H7N4O4P; [M-H]-; delta(ppm) -1.514451
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.133; C4H6N4O3; [M+Cl]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.248; C2H3FN6O4; [M-H]-; delta(ppm) 1.123262
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.833; C2H6N6O3S; [M-H]-; delta(ppm) -10.422354
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.635; CH7FN4O4; [M+Cl]-; delta(ppm) -110599.105326
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.432; CH5N7O3P; [M-H]-; delta(ppm) 5.441917
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.378; H9N5O3P; [M+Cl]-; delta(ppm) -110595.689133
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.016; C2H4N7O2; [M+Cl]-; delta(ppm) -110588.919516
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.425; C5H2N6O3; [M-H]-; delta(ppm) 7.043400
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.516; C5H10N2O2S2; [M-H]-; delta(ppm) 9.470202
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.361; C7H4N3O4; [M-H]-; delta(ppm) 0.087010
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.500; C9H6O5; [M-H]-; delta(ppm) -6.869283
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.881; C7H5F3O3; [M-H]-; delta(ppm) 5.799679
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.605; C6H8NO4; [M+Cl]-; delta(ppm) -110599.925035
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.191; C4H7F3NO2; [M+Cl]-; delta(ppm) -110589.903351
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.496; C7H6F2NO; [M+Cl]-; delta(ppm) -110585.220237
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H6N4O3; [M+Cl]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7ClN4O3; [M-H]-; delta(ppm) -110594.422309
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 13.000; POJWUDADGALRAB-UHFFFAOYSA-N; C4H6N4O3; Allantoin - 40.0 eV
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; AAGSVSIRUBZUSD-UBTZLJEENA-N; [M-H]-; C\C(Cl)=C\C[C@@H](O)C(\C)=C\Cl
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.515; XKTKHUXAWUXQOJ-UHFFFAOYSA-N; [M-H]-; NC1=C(OC=CC#N)C=CC(Cl)=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.286; AGLNTFQAHIRTFA-UHFFFAOYSA-N; [M-H]-; ClCC1=NN=C(O1)C=2C=CC=CC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.222; MJMACUIRWXDBHT-UHFFFAOYSA-N; [M-H]-; OC1=CN(N=C1)C1=CC=C(Cl)C=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; OZNMEZAXFKUCPN-UHFFFAOYSA-N; [M-H]-; OC1=CC2=C(C(O)=C1)C(=O)C(O)=CO2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.629; POJWUDADGALRAB-UHFFFAOYNA-N; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.713; MLVVTNIFHMERMU-UHFFFAOYSA-N; [M+Cl]-; 1-(5-hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.197; NHZGRUILDDFUNP-UHFFFAOYSA-N; [M-H]-; pyrrolidin-1-yl N,N-bis(sulfanyl)carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.142; NSDVPAHANCHBFV-UHFFFAOYSA-N; [M-H]-; 6,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.090; XALJYYXRQJOGCG-UHFFFAOYSA-N; [M-H]-; 5,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.038; OZNMEZAXFKUCPN-UHFFFAOYSA-N; [M-H]-; UNPD49272
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.038; XYKPFVCEJGWEPX-UHFFFAOYSA-N; [M-H]-; UNPD134569
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; CNTKQZXDAYRFBY-UHFFFAOYSA-N; [M-H]-; 4,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; FNYQCLTWIHHCQV-UHFFFAOYSA-N; [M-H]-; 4,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; VIIPQXJHKXQJKY-UHFFFAOYSA-N; [M-H]-; 2-(2H-1,3-benzodioxol-5-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; WVPYGTHKWYSUNM-UHFFFAOYSA-N; [M-H]-; 3-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-(carboxycarbonyl)benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; LUODACDZXGGDIL-UHFFFAOYSA-N; [M-H]-; 3,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.986; OJIYXYUCRVFSRV-UHFFFAOYSA-N; [M-H]-; 3,4,8-Trihydroxycoumarin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XALJYYXRQJOGCG-UHFFFAOYSA-N; [M-H]-; 5,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MLVVTNIFHMERMU-UHFFFAOYSA-N; [M+Cl]-; 1-(5-hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.985; NSDVPAHANCHBFV-UHFFFAOYSA-N; [M-H]-; 6,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.977; OZNMEZAXFKUCPN-UHFFFAOYSA-N; [M-H]-; UNPD49272
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.977; XYKPFVCEJGWEPX-UHFFFAOYSA-N; [M-H]-; UNPD134569
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.958; FNYQCLTWIHHCQV-UHFFFAOYSA-N; [M-H]-; 4,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.958; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.740; POJWUDADGALRAB-UHFFFAOYNA-N; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.609; VIIPQXJHKXQJKY-UHFFFAOYSA-N; [M-H]-; 2-(2H-1,3-benzodioxol-5-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.609; WVPYGTHKWYSUNM-UHFFFAOYSA-N; [M-H]-; 3-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.609; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-(carboxycarbonyl)benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.576; CNTKQZXDAYRFBY-UHFFFAOYSA-N; [M-H]-; 4,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.576; LUODACDZXGGDIL-UHFFFAOYSA-N; [M-H]-; 3,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.545; OJIYXYUCRVFSRV-UHFFFAOYSA-N; [M-H]-; 3,4,8-Trihydroxycoumarin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NHZGRUILDDFUNP-UHFFFAOYSA-N; [M-H]-; pyrrolidin-1-yl N,N-bis(sulfanyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.848; POJWUDADGALRAB-UHFFFAOYSA-N; [M+Cl]-; (2,5-dioxoimidazolidin-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.543; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; JZAXSONNGUOWCS-UHFFFAOYSA-N; [M-H]-; 3-methyl-2-(3-methylthiophen-2-yl)thiophene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; ZKQAFLPPDHWQCK-UHFFFAOYSA-N; [M-H]-; (1,1-dioxothiolan-3-yl)thiourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.874; FZWZZYUAWYMFBS-UHFFFAOYSA-N; [M-H]-; 6,8-dihydroxy-3H-cyclohepta[c]furan-1,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.602; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxychromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.464; DHHVHVIUTWJSFR-OWOJBTEDSA-N; [M-H]-; 6-oxo-5-[(E)-3-oxoprop-1-enyl]pyran-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.464; IQBFGXJTTIFUFR-OWOJBTEDSA-N; [M-H]-; 6-oxo-4-[(E)-3-oxoprop-1-enyl]pyran-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.262; OMWWLAWOSZODOO-UHFFFAOYSA-N; [M-H]-; 5-hydroxy-5H-furo[3,4-f][1,3]benzodioxol-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; JFEONFYENHQOBL-UHFFFAOYSA-N; [M+Cl]-; 2-(4-nitrotriazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; BJSXXQGVZDMVEM-UHFFFAOYSA-N; [M-H]-; 2-(cyclopropylsulfamoyl)ethanethioamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; PNODFDYINILVKZ-UHFFFAOYSA-N; [M-H]-; 4-formylphthalic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; CEPNDKRJQPJVNM-UHFFFAOYSA-N; [M-H]-; 2,4-dihydroxybenzene-1,3,5-tricarbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -8.904; POJWUDADGALRAB; [M+Cl]-; Allantoi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.798; MLVVTNIFHMERMU; [M+Cl]-; allantoin, enol-form
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.534; MCSNAXPUEZZHNA; [M+Cl]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.419; POJWUDADGALRAB; [M+Cl]-; Allantoi
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -2.243; POJWUDADGALRAB; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -69.394; MLVVTNIFHMERMU; [M+Cl]-; 1-(5-Hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.234; SZFCYOOEOMZUHL; [M-H]-; 3-(Carbamoylamino)-1-(2-chloroacetyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.818; MCSNAXPUEZZHNA; [M+Cl]-; 3-Methyl-4-furoxancarbohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -359.055; FGIUDZGQIRZHBT; [M-H]-; Azido 2-amino-2-chloro-3-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.455; POJWUDADGALRAB; [M+Cl]-; Allantoin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Allantoin, POJWUDADGALRAB-UHFFFAOYSA-N; Matching to 13 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000462;
CH$NAME: Allantoin
CH$NAME: (2,5-dioxoimidazolidin-4-yl)urea
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H6N4O3
CH$EXACT_MASS: 158.043990
CH$SMILES: C1(C(=O)NC(=O)N1)NC(=O)N
CH$IUPAC: InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)
CH$LINK: INCHIKEY POJWUDADGALRAB-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:204
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.968
MS$FOCUSED_ION: ION_TYPE [M+Cl]-
MS$FOCUSED_ION: PRECURSOR_M/Z 193.012921
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-01pk-9300000000-6119658eb6c3a77776ae
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  34.9687732 635.1949 34.968753 7.4638 183.47 0.6094 30 ?
  71.0243730 154.9046 71.024330 8.7716 65.76 0.6656 35 f{C2H3N2O1}/-10.04ppm,p-Cl1C4H3N2O2
  97.0031585 999.0000 97.003110 6.0720 208.91 1.0000 37 f{C3H1N2O2}/-12.29ppm,p-Cl1C3H5N2O1
  114.0300174 672.3186 114.029975 7.3226 162.67 0.8246 40 f{C5H6O3}/-19.51ppm,p-Cl1C1N4
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  34.968773 635.19 635
  71.024373 154.90 154
  97.003159 999.00 999
  114.030017 672.32 672
//
